Related Topics:
Facility ID: 4537WBBTTL1ABBT
Facility Name and Address: ABBOTT LABORATORIES 1 ABBOTT PARK WAY TIPP CITY, OH 45371 Parent Company: ABBOTT LABORATORIES Industry: Fluid Milk Manufacturing (311511) Chemical: Peracetic acid Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000079210
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2022 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA validated process utilizing Peracetic Acid. No known substitutes or alternative technologies are currently being explored. |
|
2021 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA validated process utilizing Peracetic Acid. No known substitutes or alternative technologies are currently being explored. |
|
2020 |
Source Reduction:: W14: Changed production schedule to minimize equipment and feedstock changeovers[-15-24%]
|
Methods to Identify SR Opportunities: T11: Other
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies. |
W14: Production schedule change due to commercial demand allow for more efficient production with fewer cleaning. Source Reduction - Production schedule change due to commercial demand allow for more efficient production with fewer cleaning . Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA validated process utilizing Peracetic acid. No known substitutes or alternative technologies are currently being explored. |
2019 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA validated process utilizing Peracetic acid. No known substitutes or alternative technologies are currently being explored. |
|
2017 |
Other Barriers to Source Reduction - 2017: No known substitutes or alternative technologies currently being utilized. Looking forward, 2018 may reflect a decrease on Peracetic Acid consumed per unit produced based on reduction activities currently being implemented. |